Results 121 to 130 of about 65,159 (298)
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background
BiomedicinesBackground/Objectives: Cognitive impairment often occurs in various parkinsonian syndromes. The course of deficits in cognitive functions ranges from mild cognitive decline to severe deterioration. Affected cognitive domains are also variable.
Christos Koros +4 more
doaj +1 more source
Ocular Motor Abnormalities in Functional Neurological Disorder: A Video‐Oculography Study
Movement Disorders Clinical Practice, EarlyView.Abstract Background Functional neurological disorders (FND) can include various sensory, motor or cognitive symptoms. Eye movement recordings, measured through video‐oculography, could serve as biomarkers for characterizing these dysfunctions in FND.
Aude Sangare +13 more
wiley +1 more source
0269 Non-REM sleep Hypertonia in Parkinsonian-Spectrum Disorders [PDF]
, 2022 Daniel J. Levendowski +12 more
openalex +1 more source
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a mutation in the huntingtin gene on chromosome 4, leading to progressive cognitive decline, motor impairment, and functional disability. Falls represent the leading cause of nursing home placement in HD.
Japleen Kaur +7 more
wiley +1 more source
Neuropsychiatric symptoms and PET imaging characteristics in patients with Parkinson-plus syndromes
Chinese Journal of Contemporary Neurology and Neurosurgery, 2017 Objective To explore the neuropsychiatric symptoms and 18F-fluoro-2-deoxy-D-glucose (18F-FDG) PET imaging features of Parkinson-plus syndromes. Methods There were 8 patients with probable Parkinson-plus syndromes, including one case of multiple ...
Miao ZHANG +4 more
doaj
Asymmetric Parietal Cortical Atrophy in a Patient with RAB39B‐Associated Parkinsonism
Movement Disorders Clinical Practice, EarlyView.
Luca Gallo +8 more
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma +14 more
wiley +1 more source
Apraxia in progressive nonfluent aphasia [PDF]
, 2010 The clinical and neuroanatomical correlates of specific apraxias in neurodegenerative disease are not well understood. Here we addressed this issue in progressive nonfluent aphasia (PNFA), a canonical subtype of frontotemporal lobar degeneration that has
Rohrer, J.D., Rossor, M.N., Warren, J.D.
core
A New Phenotype–Genotype Correlation for FIG4 and Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Iro Boura +4 more
wiley +1 more source